ArticleFrontiers in endocrinology2025

Case Report: Efficacy and safety of dose-escalated Mazdutide, a GLP-1/GCGR dual agonist, in an adolescent with obesity, type 2 diabetes, and hyperuricemia.

Wenfei Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.